Skip to content

Vida Ventures Advisors, LLC

Follow

13F filer, CIK 1831423, BOSTON, MA

Vida Ventures Advisors, LLC reported $29,373,266 across 2 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-03.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-25-004558

Period
2025-09-30
Reported value
$29.4M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001172661-25-004558, largest first. % of portfolio is the value over $29,373,266, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: not reported; 2024Q1: 4,523,924 shares; 2024Q2: 4,523,924 shares; 2024Q3: 4,523,924 shares; 2024Q4: 4,523,924 shares; 2025Q1: 4,523,924 shares; 2025Q2: 4,523,924 shares; 2025Q3: 4,523,924 shares 4,523,924$27.1M92.41%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 1,798,163 shares; 2024Q1: 1,798,163 shares; 2024Q2: 1,798,163 shares; 2024Q3: 1,798,163 shares; 2024Q4: 1,798,163 shares; 2025Q1: 1,798,163 shares; 2025Q2: 1,798,163 shares; 2025Q3: 1,798,163 shares 1,798,163$2.23M7.59%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-25-004558 base2025-11-03acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001172661-25-004558 Quarter ended 2025-09-302025-11-03acceptance time not in the bulk data set
13F-HR 0000950123-25-006247 Quarter ended 2025-06-302025-07-10acceptance time not in the bulk data set
13F-HR 0000950123-25-003299 Quarter ended 2025-03-312025-04-03acceptance time not in the bulk data set
13F-HR 0000950123-25-000395 Quarter ended 2024-12-312025-01-21acceptance time not in the bulk data set
13F-HR 0000950123-24-009559 Quarter ended 2024-09-302024-10-08acceptance time not in the bulk data set
13F-HR 0000950123-24-006464 Quarter ended 2024-06-302024-07-10acceptance time not in the bulk data set
13F-HR 0000950123-24-003271 Quarter ended 2024-03-312024-04-12acceptance time not in the bulk data set
13F-HR 0000950123-24-000049 Quarter ended 2023-12-312024-01-05acceptance time not in the bulk data set
13F-HR 0000950123-23-008652 Quarter ended 2023-09-302023-10-03acceptance time not in the bulk data set
13F-HR 0000950123-23-006173 Quarter ended 2023-06-302023-07-19acceptance time not in the bulk data set
13F-HR 0000950123-23-003235 Quarter ended 2023-03-312023-04-13acceptance time not in the bulk data set
13F-HR 0000950123-23-001109 Quarter ended 2022-12-312023-02-08acceptance time not in the bulk data set
13F-HR 0000950123-22-010047 Quarter ended 2022-09-302022-10-05acceptance time not in the bulk data set
13F-HR 0000950123-22-007224 Quarter ended 2022-06-302022-07-15acceptance time not in the bulk data set
13F-HR 0000950123-22-004532 Quarter ended 2022-03-312022-05-04acceptance time not in the bulk data set
13F-HR 0000950123-22-001712 Quarter ended 2021-12-312022-02-10acceptance time not in the bulk data set
13F-HR 0000950123-21-014994 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0000950123-21-010554 Quarter ended 2021-06-302021-08-12acceptance time not in the bulk data set
13F-HR 0000950123-21-005858 Quarter ended 2021-03-312021-05-11acceptance time not in the bulk data set
13F-HR 0000950123-21-002036 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0000950123-20-011531 Quarter ended 2020-09-302020-11-12acceptance time not in the bulk data set